We are excited to announce the expansion of our SERION antigens portfolio with the addition of new products designed for superior performance. We are proud to launch the Recombinant Tick-Borne Encephalitis Virus Envelope Protein E (BA112R01) and the Recombinant Human Parvovirus B19 VP2 VLP (BA122R01), both optimized for enhanced ELISA and CLIA assays.
In addition to our well-established native Varicella Zoster Virus (VZV) antigens (BA104VS and BA104VSG) and the recombinant VZV Envelope Glycoprotein E(BA104R02),we are now offering the Recombinant VZV Glycoprotein B (BA104R03) as another reliable option for efficient IgG detection.
Explore our full VZV product portfolio here.
If you have any further questions about our SERION antigens, please feel free to get in touch with us: immunologics@ virion-serion.de